Bank Of America Corp Neuro Bo Pharmaceuticals, Inc. Transaction History

Bank Of America Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$1.22 - $2.5 $159 - $327	-131 Reduced 35.31%	240 $0
Q3 2021 Nov 15, 2021	SELL	$2.73 - $4.52 $1,886 - $3,123	-691 Reduced 65.07%	371 $1,000
Q2 2021 Sep 13, 2021	BUY	$2.74 - $4.63 $2,909 - $4,917	1,062 New	1,062 $4,000

Ticker NRBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 888,693
Market Cap $2.4M
Description
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the tr...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.